electroCore Inc.

15.88
-0.02 (-0.13%)
At close: Jan 21, 2025, 3:59 PM
15.70
-1.13%
After-hours Jan 21, 2025, 07:32 PM EST
undefined%
Bid 15.6
Market Cap 104.09M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.74
PE Ratio (ttm) -9.13
Forward PE n/a
Analyst Strong Buy
Ask 16.7
Volume 104,243
Avg. Volume (20D) 135,353
Open 15.90
Previous Close 15.90
Day's Range 15.35 - 16.24
52-Week Range 5.32 - 18.67
Beta undefined

About ECOR

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or i...

Sector Healthcare
IPO Date Jun 22, 2018
Employees 68
Stock Exchange NASDAQ
Ticker Symbol ECOR

Analyst Forecast

According to 1 analyst ratings, the average rating for ECOR stock is "Strong Buy." The 12-month stock price forecast is $25, which is an increase of 57.43% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

electroCore Inc. is scheduled to release its earnings on Mar 12, 2025, during market hours.
Analysts project revenue of $7.08M, reflecting a 36.39% YoY growth and earnings per share of -0.24, making a -60.66% decrease YoY.
1 month ago
+11.06%
ElectroCore shares are trading higher after HC Wai... Unlock content with Pro Subscription